BILLS-119hr1082rh.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (18)
2025
2022
JUNE 12
22:39 Jun 12
1271.10(a
19
year
1
year
3 years
year
annually
FEBRUARY 6, 2025
1ST SESSION H. R. 1082
January
9
1, 2019
later than 60 days
each subsequent day
30, 2026
January 1, 2019
21
EVENT (1)
SESSION
H. R. 1082
GPE (2)
the United States
the United States of America
ORG (27)
ssavage
Health and Human Services
SEC
the Commissioner of Food and Drugs
CONGRESS
the Committee of the Whole House
Health and Human
Services
Senate
the Shandra Eisenga Human Cell
UCTS
Food and Drug Administration
MENTS
IB
Union Calendar No.
the Public Health Service Act
Drug Administration
the Tissue Reference Group
FF
House of Representa-
the Committee on Energy and Commerce
the Commissioner of Food and
4
Drugs
the Food and Drug Admin-
the State of the Union
THE HOUSE OF REPRESENTATIVES
the Food and Drug Administration
Group of the Food and Drug Administration
the Food and Drug Omnibus Reform Act
PERSON (3)
MOOLENAAR
DINGELL
Shandra Eisenga
4
Human Cell and Tissue Product Safety Act
Topic Classifications
congressional legislation
95.1%
government oversight
61.4%
public health
44.1%
Extracted Keywords
human cell
cell tissue
tissue
tissue products
cell
reference group
tissue reference
products
human
evidence based
cells
violation
civil penalty
product safety
campaign
Forensic Analysis
PDF Metadata
- Creator
- U.S. Gov. Printing Office -- G.S.D.D.
- ModDate
- D:20250613053344Z
- Producer
- Acrobat Distiller 25.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20250612230926-04'00'
Sentiment
Polarity
Neutral
0.031
Subjectivity
29%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.